Преждевременный разрыв плодных оболочек. Преждевременное излитие вод

01.10.2013
1105

ФГБУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздрава России, Москва

Скачать PDF

Список литературы

  1. Болотских В.М. Опыт применения мифепристона при преждевременном излитии околоплодных вод. Российский вестник акушера-гинеколога. 2010; 3: 32-5.
  2. Козлов В.В., Веселов А.В. Амоксициллин/сульбактам – новый представитель ингибиторозащищенных бета-лактамов. Клиническая микробиология и антимикробная терапия. 2006; 8(2): 173-85.
  3. Ортенберг Э.А., Ушакова М.А., Вешкурцева И.М., Рожаев М.В. Ингибиторозащищенные бета-лактамы: место в современных схемах антибактериальной терапии. Клиническая микробиология и антимикробная терапия. 2005; 7(4): 393-402.
  4. Радзинский В.Е., Ордиянц И.М., ред. Преждевременный разрыв плодных оболочек. Информационное письмо. М.: Медиабюро Status Preasens; 2011. 20 с.
  5. Преждевременные роды. Клинический протокол. М.: ФГУ «НЦ АГи П им. В.И. Кулакова» Минздравсоцразвития РФ/Проект «Мать и Дитя»; 2010.
  6. Alfirevic Z., Kelly A.J., Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst. Rev. 2009; (4): CD003246.
  7. American College of Obstetricians and Gynecologists; Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 127: Management of preterm labor. Clinical management guidelines for obstetrician-gynecologists. Obstet. Gynecol. 2012; 113(6): 1308-17.
  8. American College of Obstetricians and Gynecologists; Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 80: Рremature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet. Gynecol. 2007; 109(4): 1007-19.
  9. Buchanan S.L., Crowther C.A., Levett K.M., Middleton P., Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst. Rev. 2010; (3): CD004735.
  10. Brownfoot F.C., Crowther C.A., Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk preterm birth. Cochrane Database Syst. Rev. 2008; (4): CD006764.
  11. CaugheyA.B., StotlandN.E., WashingtonA.E., Escobar G.J. Maternal and obstetric complications of pregnancy are associated with increasing gestational age at term. Am. J. Obstet. Gynecol. 2007; 196(2): 155; e1-6.
  12. Crowther C.A., McKinlay C.J.D., Middleton P., Harding J.E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst. Rev. 2011; (6): CD003935. doi: 10.1002/14651858.CD003935.pub3.
  13. Crowther C.A., Hiller J.E., Doyle L.W. Magnesium sulphatefor preventing preterm birth in threated preterm labour. Cochrane Database Syst. Rev.2002; (4): CD001060. doi: 10.1002/14651858.CD001060.
  14. Doyle L.W., Crowther C.A., Middleton P., Marret S., Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst. Rev. 2009; (1): CD004661.
  15. Dare M.R., Middleton P., Crowther C.A., Flenady V.J., Varatharaju B. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).Cochrane Database Syst. Rev.2007; (4): CD005302. doi: 10.1002/14651858.CD005302.pub2.
  16. Di Renzo G.C., Cabero Roura L., Facchinetti F.; the EAPM-Study Group on "Preterm Birth". Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J. Matern. Fetal Neonatal Med. 2011; 24(5): 659–67.
  17. Ehsanipoor R.M., Shrivastava V.K., Lee R.M., Chan K., Galyean A.M., Garite T.J. et al. A randomized, double-masked trial of prophylactic indomethacin tocolysis versus placebo in women with premature rupture of membranes. Am. J. Perinatol. 2011; 28(6): 473-8.
  18. Flenady V., King J. Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database Syst. Rev. 2002; (3): CD001807.
  19. Husslein P., Cabero Roura L., Dudenhausen J.W., Helmer H., Frydman R., Rizzo N., Schneider D. Atosiban versus usual care for the management of preterm labor. J. Perinat. Med. 2007; 35(4): 305–13.
  20. Hapangama D., Neilson J.P. Mifepristone for induction of labour. Cochrane Database Syst. Rev. 2009; (3): CD002865.
  21. Hakansson S., Axemo P., Bremme K., Bryngelsson A.L., Wallin M.C., Ekström C.M. et al.; Swedish Working Group For The Prevention of Perinatal Group B Streptococcal Infections. Group B streptococcal car­riage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstet. Gynecol. Scand. 2008; 87(1): 50–8.
  22. Hernаndez В.A., Lоpez J.A., Gаmez G.C. Comparison of maternal and perinatal outcomes in the conservative treatment preterm premature membrane rupture between the use of erythromycin and clindamycin. Ginecol. Obstet. Mex. 2011; 79(7): 403-10.
  23. Hannah M., Ohlsson A., Farine D., Hewson S.A., Hodnett E.D., Myhr T.L. et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N. Engl. J. Med. 1996; 334(16):1005-10.
  24. Kashanian M., Akbarian A.R., Soltanzadeh M. Atosiban andnifedipine for the treatment of preterm labor. Int.J. Gynecol. Obstet.2005; 91: 10–4.
  25. Kenyon S., Boulvain M., Neilson J.P. Antibiotics for preterm rupture of membranes. Cochrane Database Syst. Rev. 2010; (8): CD001058. doi: 10.1002/14651858.CD001058.pub2.
  26. Kunt C., Kanat-Pektas M., Gungor A.N., Kurt R.K., Ozat M., Gulerman C. et al.Randomized trial of vaginal prostaglandin E2 versus oxytocin for labor induction in prematureruptureofmembranes. Taiwan J. Obstet. Gynecol.2010; 49(1): 57-61.
  27. Mackeen A.D., Seibel-Seamon J., Grimes-Dennis J., Baxter J.K., Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst. Rev. 2011; (10): CD007062. doi:10.1002/14651858.CD007062.pub2.
  28. McKinlay C.J.D., Crowther C.A., Middleton P. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am. J. Obstet. Gynecol.2012; 206(3): 187-94.
  29. Mittal P., Romero R., Soto E., Cordoba M., Chang C.L., Vaisbuch E. A role for placental alpha-microglobulin-1 in the identification of women with a sonographic short cervix at risk for spontaneous rupture of membranes. Am. J. Obstet. Gynecol. 2009; 201(6, Suppl.): S196-7.
  30. Neil P.R.L., Wallace E.M. Is AmniSure® useful in the management of women with prelabor rupture of the membranes? Aust. N. Z. J. Obstet. Gynaecol. 2010; 50(6): 534-8.
  31. Ohlsson A., Shah V.S. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst. Rev. 2009; (3): CD007467.
  32. Park K.H., Kim S.N., Oh K.J., Lee S.Y., Jeong E.H., Ryu A. Noninvasive prediction of intra-amniotic infection and/or inflammation in preterm premature rupture of membranes. Reprod. Sci. 2012; 19(6): 658-65.
  33. Popowski T., Goffinet F., Maillard F., Schmitz T., Leroy S., Kayem G. Maternal markers for detecting early-onset neonatal infection and horioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study. BMC Pregnancy Childbirth. 2011, 11: 26.
  34. Royal College of Obstetricians and Gynaecologists; RCOG Clinical Effectiveness Support Unit. Induction of labour. Evidence-based Clinical Guideline Number 9. London: RCOG Press; 2001.
  35. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 2006; (3): CD004454.
  36. Shatrov J.G., Birch S.C., Lam L.T., Quinlivan J.A., McIntyre S., Mendz G.L. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet. Gynecol.2010; 116(2, Pt 1): 387–92.
  37. Silva E., Martinez J.C. Diagnosing ROM: a comparison of the gold standard, indigo carmine amnioinfusion, to the rapid immunoassay, the AmniSure ROM test. J Perinat. Med. 2009; 37(Suppl.1): 956.
  38. Sweet D.G., Carnielli V., Greisen G., Hallman M., Ozek E., Plavka R. et al.; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology. 2010; 97(4): 402-17.
  39. Tagore S., Kwek K. Comparativeanalysisofinsulin-like growth factor binding protein-1 (IGFBP1), placental alpha-microglobulin-1 (PAMG-1) and nitrazine test to diagnose premature rupture of membranes in pregnancy. J. Perinat. Med.2010; 38(6): 609-12.
  40. Tan B.P., Hannah M.E. Oxytocin for prelabour rupture of membranes at or nearterm. Cochrane Database Syst. Rev. 2007; (2): CD000157.
  41. Tran S.H., Cheng Y.W., Kaimal A.J., Caughey A.B. Lengh of rupture of membranes in the setting of premature rupture of membranes at term and infectious morbidity. Am. J. Obstet. Gynecol. 2008; 198: 700; е1-5.
  42. Yudin M.H., van Schalkwyk J., Van Eyk N., Boucher M., Castillo E., Cormier B. et al.; Society of Obstetricians and Gynaecologists of Canada. Antibiotic therapy in preterm premature rupture of the membranes. J. Obstet. Gynaecol. Can. 2009; 31(9): 863-7; 868-74.
  43. Van de Laar R., van der Ham D.P., Oei S.G., Willekes C., Weiner C..P, Mol B.W. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 147(2): 124-9.
  44. Wing D.A., Guberman C., Fassett M. A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation. Am. J. Obstet. Gynecol. 2005; 192(2): 445-51.

Об авторах / Для корреспонденции

Баев Олег Радомирович, доктор медицинских наук, профессор, заведующий родильным отделением ФГБУ НЦАГиП им. В.И. Кулакова Минздрава России, профессор кафедры акушерства, гинекологии, перинатологии и репродуктологии ГБОУ ВПО Первого МГМУ им. И.М. Сеченова Минздрава России
Адрес: 117997, Москва, ул. Академика Опарина, д. 4. Телефон: 8 (495) 438-11-88. E-mail: o_baev@oparina4.ru

Нет комментариев

Комментариев: 0

Вы не можете оставлять комментарии
Пожалуйста, авторизуйтесь